CareLit · DOI-Nachweis · Pneumologie
Expression, overrepresentation and mutations of EGFR in early-stage lung cancer
DOI 10.1055/s-2008-1074242
Bibliografische Angaben
Nachweis in CareLit
Autor:innenS Bode, S Scheil-Bertram, A Kruger, A Fisseler-Eckhoff
ZeitschriftPneumologie
Ausgabe04/2008
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Since the introduction of tyrosine kinase inhibitors in therapy of Non Small Cell Lung Cancer (NSCLC) most studies on Epidermal Growth Factor Receptor (EGFR) aim at EGFR as prognostic and predictive factor in advanced NSCLC. While EGFR mutations are established as predictive and prognostic markers, the predictive and prognostic value of EGFR DNA-overrepresentation is discussed controversely. Moreover EGFR status mea…
Zitieren
Zitierempfehlung
S Bode, S Scheil-Bertram, A Kruger, A Fisseler-Eckhoff (2008) Expression, overrepresentation and mutations of EGFR in early-stage lung cancer. Pneumologie (04). https://doi.org/10.1055/s-2008-1074242
Mit CareLit weiterarbeiten